| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |